Skip to main content
. 2005 Aug;58(8):833–838. doi: 10.1136/jcp.2004.023416

Table 1.

 Relations between p-STAT3 immunoreactivity and the pathological features of the tumours

N p-STAT3 immunoreactivity* (%)
+
Normal epithelium 15 0 (0.0) 15 (100)
Adenoma† 44 8 (18.2) 36 (81.8)
Total adenocarcinomas 95 69 (72.6) 26 (27.4)
Differentiation
    Well 45 29 (64.4) 16 (35.6)
    Moderate 41 34 (82.9) 7 (17.1)
    Poor 3 1 (33.3) 2 (66.7)
    Mucinous carcinoma 6 5 (83.3) 1 (16.7)
Grade of tumour invasion‡
    Tis 18 9 (50.0) 9 (50.0)
    T1 8 4 (50.0) 4 (50.0)
    T2 5 2 (40.0) 3 (60.0)
    T3 61 51 (83.6) 10 (16.4)
    T4 3 3 (100.0) 0 (0.0)
Lymphatic invasion
    Absent 30 18 (60.0) 12 (40.0)
    Present 65 51 (78.5) 14 (21.5)
Venous invasion§
    Absent 58 37 (63.8) 21 (36.2)
    Present 37 32 (86.5) 5 (13.5)
Lymph node metastasis§
    Absent 62 40 (64.5) 22 (35.5)
    Present 33 28 (84.4) 5 (15.2)
Dukes’classification¶
    A 31 15 (48.4) 16 (51.6)
    B 30 25 (83.3) 5 (16.6)
    C 31 26 (83.9) 5 (16.1)
    D 3 3 (100.0) 0 (0.0)

*See Materials and Methods for classification of staining intensity; †Significant difference between total adenocarcinomas and adenomas (p<0.001), χ2 for independence test; ‡p<0.01, Mann-Whitney’s U test; §p<0.05, χ2 for independence test; ¶p<0.001, Mann-Whitney’s U test.

p-STAT, phosphorylated (activated) signal transducer and activator of transcription.